MARKETS / NYSE / LXU
NYSE · INDUSTRIAL INORGANIC CHEMICALS · MID CAP

LSB Industries, Inc. LXU

17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$615.2M
▲ 17.8% vs FY2024
EPS · FY25
$0.34
Dividend / sh · FY25
Payout · FY25
ROE · FY25
4.9%
Net margin · FY25
4.0%
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 615.2M
Revenue, FY2025 · full 17-year series below
Revenue Net income
0.250.50.7510.60.02009201220152018202120242025
0.250.50.7510.60.02016201920222025

4 cents of every revenue dollar became profit this year.

Per share
USD 0.34
Diluted EPS, FY2025
EPS
240.342009201220152018202120242025
240.342016201920222025

The company pays no cash dividend.

Profitability
4.9%
Return on equity, FY2025
ROE
2040604.9%2009201220152018202120242025
2040604.9%2016201920222025
Operating margin9.3%
Net margin4.0%
Return on assets2.1%

Each USD of equity produced 5 cents of profit this year.

Returned to shareholders
returned in FY2025 · dividends + net buybacks
Dividends paid
Net buybacks
Share of profit
Consecutive raises

Growth
+11.9% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−12.0%
+11.9%
+3.5%
+0.1%
Net income
−52.5%
−1.2%
EPS, diluted
−49.8%
−8.6%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
Shares outstanding, FY2025
0.050.052009201220152018202120242025
0.050.052016201920222025
Change, 5 years
Change, 10 years

A share split breaks the comparison across the period, so we leave it out.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 1.2B
total assets, end of FY2025
Total assetsUSD 1.2B
EquityUSD 520.0M
CashUSD 19.5M
Gross debtUSD 441.1M
Net debtUSD 421.5M
Current ratio2.78×

Net debt stands at 81% of equity.

History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
0.6
0.5
0.6
0.9
0.6
0.4
0.4
0.4
0.4
0.4
0.4
0.5
0.7
0.8
0.8
0.6
0.5
Operating income $B
0.1
−0.0
0.1
0.3
0.1
−0.0
−0.0
−0.0
−0.0
−0.1
−0.1
0.0
0.1
0.1
0.1
0.1
0.0
EBITDA $B
0.1
0.1
0.1
0.4
0.2
0.1
0.0
0.0
0.0
−0.0
−0.0
0.1
0.1
0.1
0.2
0.1
0.1
Income tax $B
0.0
−0.0
0.0
0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
0.0
−0.0
0.0
0.2
0.0
−0.1
−0.1
−0.1
−0.0
0.1
−0.0
0.0
0.1
0.1
0.1
0.0
0.0
EPS, diluted $
0.34
−0.27
0.37
2.68
−4.40
−2.71
−2.65
−3.74
−2.18
2.54
−1.67
0.85
2.33
2.49
3.58
1.32
0.96
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
4.9
−3.8
5.4
47.2
14.3
−31.2
−21.5
−18.5
−6.3
24.5
−8.1
4.6
14.3
18.1
35.5
17.9
14.3
Shares out B
·
·
·
·
0.05
·
·
·
·
·
·
·
·
·
·
·
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
66 of 66
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed